Warpaint London PLC (GB:W7L)
LSE:W7L
Want to see GB:W7L full AI Analyst Report?
Top Page
Warpaint London
(LSE:W7L)
Select Model
Select Model
Rating:65Neutral
Price Target:
187.00 p
▼(-16.89% Downside)
Action:Downgraded
Date:05/01/26
The score is primarily supported by strong underlying financial quality (profitability and low leverage) and a shareholder-friendly valuation profile (high dividend yield with a moderate P/E). These positives are materially offset by weak technicals (price far below key moving averages with negative MACD) and signs of near-term fundamental cooling (slower 2025 growth and declining free cash flow).
Positive Factors
Multi-year revenue growth
Sustained revenue expansion over multiple years indicates durable product-market fit and successful channel expansion across retail, D2C and international wholesale. A larger revenue base supports scale economics, portfolio investment and resilience versus short-term market swings.
Negative Factors
2025 growth slowdown
A marked deceleration in top-line growth suggests the prior expansion pace may be fading due to market saturation, retailer rebalancing or tougher competitive dynamics. Slower revenue momentum reduces operating leverage and may constrain medium-term margin and reinvestment prospects.
Read all positive and negative factors
Positive Factors
Negative Factors
Multi-year revenue growth
Sustained revenue expansion over multiple years indicates durable product-market fit and successful channel expansion across retail, D2C and international wholesale. A larger revenue base supports scale economics, portfolio investment and resilience versus short-term market swings.
Read all positive factors
Warpaint London (W7L) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£142.99M
Dividend Yield5.97%
Average Volume (3M)769.02K
Price to Earnings (P/E)4.4
Beta (1Y)1.46
Revenue Growth3.42%
EPS Growth-24.29%
CountryUK
Employees155
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)0.18
Shares Outstanding80,787,320
10 Day Avg. Volume287,147
30 Day Avg. Volume769,020
Financial Highlights & Ratios
PEG Ratio-0.50
Price to Book (P/B)1.94
Price to Sales (P/S)1.48
P/FCF Ratio12.69
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£425.00Price Target Upside88.89% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.19
Revenue Forecast (FY)£107.85M
Warpaint London Business Overview & Revenue Model
Company Description
Warpaint London PLC, together with its subsidiaries, provides color cosmetics. It operates through two segments, Branded and Close-Out. It provides supply chain management services; and operates as a wholesaler. The company provides its products u...
How the Company Makes Money
Warpaint London makes money by selling cosmetics products it owns/markets (primarily under the W7L and Technic brands) through multiple routes to market. Its core revenue stream is product sales to third-party retailers and distributors (wholesale...
Warpaint London Financial Statement Overview
Summary
Income Statement
84
Very Positive
Balance Sheet
88
Very Positive
Cash Flow
77
Positive
| Breakdown | Dec 2025 | Dec 2024 | Mar 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 105.08M | 101.61M | 89.59M | 64.06M | 50.00M |
| Gross Profit | 41.65M | 39.63M | 33.77M | 23.33M | 16.91M |
| EBITDA | 21.77M | 26.34M | 20.45M | 11.69M | 7.55M |
| Net Income | 14.35M | 18.23M | 13.90M | 6.25M | 2.83M |
Balance Sheet | |||||
| Total Assets | 98.18M | 85.56M | 65.03M | 51.35M | 47.57M |
| Cash, Cash Equivalents and Short-Term Investments | 15.98M | 21.89M | 9.05M | 5.87M | 4.07M |
| Total Debt | 9.82M | 4.25M | 5.45M | 5.86M | 3.15M |
| Total Liabilities | 17.83M | 12.27M | 18.22M | 13.57M | 11.42M |
| Stockholders Equity | 80.35M | 73.29M | 46.80M | 37.78M | 36.15M |
Cash Flow | |||||
| Free Cash Flow | 12.25M | 6.90M | 9.77M | 7.59M | 4.49M |
| Operating Cash Flow | 14.44M | 9.14M | 10.29M | 8.43M | 5.09M |
| Investing Cash Flow | -9.15M | -2.67M | -518.00K | -843.00K | -599.00K |
| Financing Cash Flow | -11.16M | 6.39M | -6.67M | -5.52M | -5.29M |
Warpaint London Technical Analysis
Negative
225.00
Price Trends
197.55
Negative
204.13
Negative
219.95
Negative
Market Momentum
-8.97
Negative
38.35
Neutral
49.17
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:W7L, the sentiment is Negative. The current price of 225 is above the 20-day moving average (MA) of 184.08, above the 50-day MA of 197.55, and above the 200-day MA of 219.95, indicating a bearish trend. The MACD of -8.97 indicates Negative momentum. The RSI at 38.35 is Neutral, neither overbought nor oversold. The STOCH value of 49.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:W7L.
Warpaint London Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | £259.99M | 3.91 | 30.98% | 2.12% | -0.84% | -25.31% | |
65 Neutral | £142.99M | 4.36 | 18.66% | 5.97% | 3.42% | -24.29% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | £68.83M | 2.80 | 7.82% | ― | ― | ― | |
54 Neutral | £329.72M | 14.34 | -2.16% | 4.82% | 6.74% | 26.11% | |
42 Neutral | £30.35M | -0.15 | 97.34% | ― | -31.02% | -4458.82% |
* Consumer Defensive Sector Average
GB:W7L
Warpaint London
172.50
-267.27
-60.78%
GB:MCB
McBride
158.20
9.67
6.51%
GB:PZC
PZ Cussons
79.90
-3.90
-4.66%
GB:VLG
Venture Life
56.50
5.50
10.78%
GB:REVB
Revolution Beauty Group plc
3.45
-3.64
-51.34%
Warpaint London Corporate Events
Business Operations and StrategyDividendsFinancial DisclosuresM&A Transactions
Warpaint London Delivers Record Sales but Lower Profits as It Expands Brand Portfolio
Neutral
Apr 29, 2026
Warpaint London reported record 2025 revenues of £105.1m, up 3% year on year and boosted by the acquisition and integration of Brand Architekts, but profits declined as adjusted EBITDA fell 15% and profit before tax dropped 24%. Despite softe...
Business Operations and StrategyFinancial DisclosuresM&A Transactions
Warpaint London Sets Date to Unveil 2025 Audited Results
Neutral
Apr 20, 2026
Warpaint London PLC has announced it will publish its audited financial results for the year ended 31 December 2025 on 29 April 2026. The timing of the release, following the acquisition of the Barry M colour cosmetics brand in February 2026, will...
Regulatory Filings and Compliance
Warpaint London Confirms Share Capital and Option Scheme Position
Neutral
Apr 9, 2026
Warpaint London has provided an update on its share option schemes, confirming that no new shares were issued or allotted under the Company Share Option Plan (2021) and Enterprise Management Incentive Scheme during the period from 9 October 2025 t...
Business Operations and StrategyM&A TransactionsRegulatory Filings and Compliance
Warpaint London Confirms Compliance With Post-Takeover Commitments on Brand Architekts
Positive
Feb 12, 2026
Warpaint London has confirmed to the UK Takeover Panel that it has complied with the post-offer intention statements it made in connection with its acquisition of Brand Architekts Group. The deal, completed via a court-sanctioned scheme of arrange...
Business Operations and StrategyM&A Transactions
Warpaint London Completes £1.4m Acquisition of Barry M Brand
Positive
Feb 9, 2026
Warpaint London has completed the acquisition of the Barry M cosmetics brand, purchasing its intellectual property, stock and order book out of administration for £1.4m in cash, while excluding manufacturing operations and liabilities. The de...
Business Operations and StrategyFinancial DisclosuresM&A Transactions
Warpaint London buys Barry M brand as 2025 revenue edges higher
Positive
Feb 9, 2026
Warpaint London has agreed to acquire the Barry M cosmetics brand out of administration for £1.4 million in cash, taking over its intellectual property, stock and order book but not its manufacturing assets or liabilities. Barry M adds a well...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.